Concepedia

Timothy P. Newton

TP

Statistics

Publications

6

Citations

299

H-Index

6

Active since

2012

Affiliations

University of Colorado Denver(Current)

University of Colorado Anschutz Medical Campus

University of Colorado Cancer Center

University of Colorado Boulder

Timothy P. Newton is an author at University of Colorado Denver specializing in oncology, pharmacology, and molecular oncology.

Publications per year

2012–2021

6

Publications

6

Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer

Anna Spreafico, John J. Tentler, Todd M. Pitts et al. · Clinical Cancer Research · 2013 · 64 citations · Full text

, , +17

Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models

Sara A. Flanigan, Todd M. Pitts, Timothy P. Newton et al. · Clinical Cancer Research · 2013 · 59 citations · Full text

, , +17

p53 Family Members Regulate Phenotypic Response to Aurora Kinase A Inhibition in Triple-Negative Breast Cancer

John J. Tentler, Anastasia A. Ionkina, Aik Choon Tan et al. · Molecular Cancer Therapeutics · 2015 · 54 citations · Full text

, , +17

Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer

Todd M. Pitts, Timothy P. Newton, Erica L. Bradshaw‐Pierce et al. · PLoS ONE · 2014 · 52 citations · Full text

, , +15

Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models

Jennifer R. Diamond, S. Gail Eckhardt, Aik Choon Tan et al. · Clinical Cancer Research · 2012 · 45 citations · Full text

, , +16

1–5 of 6